Metraipolis › archive › dc_9ec5ca81ed50

Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind,… — Europe PMC PMID:22293030

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/22293030
DOI
10.1186/1476-511x-11-18
License (as archived)
solo-consultazione
Archived
2026-10-07T17:35:43.790Z
SHA-256 of the archived text
9e0ffec437d10b4ad29b849dc14f74c5b816df53b34b7b9dfec6466800db009a
Stable URL of this page
https://metraipolis.com/documento/dc_9ec5ca81ed50

How to cite

Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind,… — Europe PMC PMID:22293030 — Europe PMC (en), https://europepmc.org/article/MED/22293030 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9ec5ca81ed50 (Metraipolis archive dc_9ec5ca81ed50, sha256 9e0ffec437d10b4ad29b849dc14f74c5b816df53b34b7b9dfec6466800db009a)
BibTeX
@misc{dc9ec5ca81ed50,
  title = {Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind,… — Europe PMC PMID:22293030},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/22293030},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9ec5ca81ed50; sha256 9e0ffec437d10b4ad29b849dc14f74c5b816df53b34b7b9dfec6466800db009a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/22293030. Agents can read the archived copy with the MCP tool read_document.